National Cancer Institute; Notice of Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

A portion of the meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(6) and 552b(c)(9)(B), Title 5 U.S.C., as amended. The discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the review of applications, and information concerning NCI and/or its contractors, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy, and the premature disclosure of discussions related to personnel and programmatic issues would be likely to significantly frustrate the subsequent implementation of recommendations.

Name of Committee: National Cancer Advisory Board and Subcommittee on Cancer Centers.

Dates: June 12-14, 2000.

Name of Committee: Subcommittee on Cancer Centers.

Open: June 12, 7:00 p.m. to Recess.

Agenda: Cancer Centers Support Guideline Update.

Place: Bethesda Hyatt Regency, One Bethesda Metro Center, Bethesda, MD 20814, (301) 657-1234.

Contact Person: Dr. Brian Kimes, Executive Secretary, Office of Centers, Training, and Resources, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Suite 700, Bethesda, MD 20892, (301) 496-8537.

Name of Committee: National Cancer Advisory Board.

Open: June 13, 8:45 a.m. to 3:45 p.m. and June 14, 9:00 a.m. to 3:00 p.m.

Agenda: Program reports and presentations; Business of the Board. For detailed agenda: See NCI Homepage/Advisory Board and Groups, http://deainfo.nci.nik.gov/ADVISORY/boards.htm. Tentative agenda available 10 working days prior to meetings; Final agenda available 5 working days prior to meetings.

Closed: June 13, 2000, 4:00 p.m. to Recess.

Agenda: Review of Grant Applications.

Place: Building 31, C Wing, 6 Floor, Conference Room 10, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892.

Contact Person: Dr. Marvin R. Kalt, Executive Secretary, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, Room 8022, Bethesda, MD 20892-8327, (301) 496-5147.